Sign inJoin waitlistJoin the waitlist

JL

Josh Levitsky

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients · McGaw Medical Center of Northwestern University

Credentials: · · ·

History

McGaw Medical Center of Northwestern University
Present

Gastroenterology
2001–2004
Internal Medicine
1998–2001
Albert Einstein College of Medicine
1994–1998

Research

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
American Journal of Transplantation · 2016 · 494 citations
An interferon-free antiviral regimen for HCV after liver transplantation
New England Journal of Medicine · 2014 · 338 citations
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients
Systematic review or meta-analysis · Annals of Internal Medicine · 2005 · 285 citations

Michael Abecassis
36 papers · 1 as a fellow
Daniela Ladner
21 papers · 6 as a fellow
Lisa VanWagner
16 papers
John Friedewald
15 papers
Lorenzo Gallon
15 papers
Joseph Leventhal
14 papers
Anton Skaro
12 papers
Sandy Feng
12 papers · 4 as a fellow
Anthony Demetris
11 papers
Jacqueline O'Leary
11 papers
Robert Brown
10 papers
Sumeet Asrani
10 papers

Grants

Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.8M · Northwestern University
2021–2028
Novel Proteoform Biomarkers of Acute Rejection in Liver Transplant Recipients
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $416.4K · Northwestern University
2018–2021
Proteomic Predictors of Chronic Kidney Disease in Liver Transplant Recipients
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $427.9K · Northwestern University
2014–2018
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $13.7K · Northwestern University
2006–2007

Clinical trials

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
Principal investigator · Active not recruiting · Phase 4
Northwestern University
2022–2024
Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation
Principal investigator · Completed
Northwestern University
2016–2021
Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Principal investigator · Terminated
Northwestern University
2014–2016
SRL (Sirolimus) Withdrawal
Principal investigator · Completed
Northwestern University
2013–2020